Anti α 4 β Prediction of treatment outcome with seven integrin antibodies

摘要

The present invention provides a method of treating a patient with an anti-α4β7 antibody, comprising predicting the outcome of the antibody therapy. The present invention relates to the identification of patients capable of responding to therapy comprising anti-α4β7 antibodies.